Search Main Menu Main Content

Choose language
Change contrast :
Standards Reinforced

icone

HAS profile

Mission
Organisational Structure
Ethics, transparency and management of conflicts of interest

International relations and projects
Publications

Recherche

icone plus
My account

Email alert Subscription

Newsletter Subscription

My search

Refresh

Please fill in your email address to retrieve your email alerts subscriptions.

New subscription

Please fill in your email address to retrieve your newsletter subscriptions.

You do not have a saved search
No element in selection
Contact

1 result

Active substance : spironolactone
Type : Opinions on products and services
Topics : Respiratory tract diseases
Topics : Mental disorders and behavioural conditions

Topic

Diagnostic and therapeutic techniques (1)
Plus ...
- Medical equipement (1)
Diseases and conditions (1)
Plus ...

Drugs, devices and medical acts (1)
Plus ...
- Opinions on products and services (1)

RESMED SAS FRANCE (1)

Français (1)

Active substance

spironolactone (1)

Première page
Page précédente
/ 1
Page suivante
Dernière page

Sorted by :Relevance

Title
Date

AUTOSET CS - 29 june 2010 (2413) - Opinion

Opinions on products and services - Posted on 06/07/2010

Download opinion

Add to my selection

Première page
Page précédente
/ 1
Page suivante
Dernière page
20 par pages

Advancing quality in the fields of health and social care services

Follow us :

Eunetha.eu
Pasq.eu

All our publications by topic and type

Opinions on medicines
Opinions on medical devices
INAHTA briefs

Français
English

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

jXpKSuDJKMzur3Ag